Condition: Colitis, Ulcerative · Sponsor: Janssen Research & Development, LLC
The purpose of this protocol is to evaluate the efficacy (how well it works), safety and tolerability of oral icotrokinra as therapy in adult and adolescent participants with moderately to severely active ulcerative colitis (UC, a chronic disease of the large intestine in which the lining of the colon becomes inflamed and develops tiny open ulcers).
This description comes directly from the study's public registry record.
Study Contact · 844-434-4210 · Participate-In-This-Study1@its.jnj.com
Always discuss trial participation with your own doctor first.
| AZ Gastro Care | Chandler, Arizona, United States | Recruiting |
| Research Solutions of Arizona | Litchfield Park, Arizona, United States | Recruiting |
| Mayo Clinic | Scottsdale, Arizona, United States | Recruiting |
| Clinnova Research | Anaheim, California, United States | Recruiting |
| Southern California Research Center | Coronado, California, United States | Recruiting |
| Om Research LLC | Lancaster, California, United States | Recruiting |
| TLC Clinical Research Inc | Los Angeles, California, United States | Recruiting |
| GastroIntestinal Bioscience | Los Angeles, California, United States | Recruiting |
| Hoag Memorial Hospital | Newport Beach, California, United States | Recruiting |
| Om Research LLC 2 | Oxnard, California, United States | Recruiting |
| Clinical Applications Laboratories, Inc | San Diego, California, United States | Recruiting |
| Medical Associates Research Group, Inc. | San Diego, California, United States | Recruiting |
+ 386 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07196748